首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of gemigliptin,a dipeptidyl peptidase‐4 inhibitor,in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24‐week,multicentre, randomized,double‐blind,placebo‐controlled study (TROICA study)
Authors:Chang Ho Ahn MD  Kyung Ah Han MD  PhD  Jae Myung Yu MD  PhD  Joo Young Nam MD  PhD  Kyu Jeung Ahn MD  PhD  Tae Keun Oh MD  PhD  Hyoung Woo Lee MD  PhD  Dae Ho Lee MD  PhD  Jaetaek Kim MD  PhD  Choon Hee Chung MD  PhD  Tae Sun Park MD  PhD  Byung Joon Kim MD  PhD  Seok Won Park MD  PhD  Hyeong Kyu Park MD  PhD  Kwang Jae Lee MD  PhD  Sang‐Wook Kim MD  PhD  Jeong Hyun Park MD  PhD  Kwan Pyo Ko MD  PhD  Chong Hwa Kim MD  PhD  Hyunjin Lee MSc  Hak Chul Jang MD  PhD  Kyong Soo Park MD  PhD
Affiliation:1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea;2. Department of Internal Medicine, Eulji General Hospital, Seoul, Korea;3. Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea;4. Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea;5. Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul, Korea;6. Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea;7. Department of Internal Medicine, Yeungnam University Medical Centre, Daegu, Korea;8. Department of Internal Medicine, Wonkwang University School of Medicine and Hospital, Iksan, Korea;9. Department of Internal Medicine, Chung‐Ang University Hospital, Seoul, Korea;10. Department of Internal Medicine, Yonsei University Wonju Severance Christian Hospital, Wonju, Korea;11. Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea;12. Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea;13. Department of Internal Medicine, CHA Bundang Medical Center, Seongnam, Korea;14. Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea;15. Department of Internal Medicine, Daedong General Hospital, Busan, Korea;16. Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea;17. Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea;18. Department of Internal Medicine, Jeju National University Hospital, Jeju, Korea;19. Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea;20. LG Life Sciences, Seoul, Korea;21. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea;22. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea;23. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea
Abstract:
Keywords:clinical trial     DPP‐4 inhibitor  phase III study
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号